436 related articles for article (PubMed ID: 16442279)
1. Can we rationally design promiscuous drugs?
Hopkins AL; Mason JS; Overington JP
Curr Opin Struct Biol; 2006 Feb; 16(1):127-36. PubMed ID: 16442279
[TBL] [Abstract][Full Text] [Related]
2. Network pharmacology: the next paradigm in drug discovery.
Hopkins AL
Nat Chem Biol; 2008 Nov; 4(11):682-90. PubMed ID: 18936753
[TBL] [Abstract][Full Text] [Related]
3. From magic bullets to designed multiple ligands.
Morphy R; Kay C; Rankovic Z
Drug Discov Today; 2004 Aug; 9(15):641-51. PubMed ID: 15279847
[TBL] [Abstract][Full Text] [Related]
4. Progress in the Rational Design for Polypharmacology Drug.
Zhou J; Li Q; Wu M; Chen C; Cen S
Curr Pharm Des; 2016; 22(21):3182-9. PubMed ID: 26907948
[TBL] [Abstract][Full Text] [Related]
5. The impact of parallel chemistry in drug discovery.
Edwards PJ
IDrugs; 2006 May; 9(5):347-53. PubMed ID: 16676271
[TBL] [Abstract][Full Text] [Related]
6. Detecting drug promiscuity using Gaussian ensemble screening.
PĂ©rez-Nueno VI; Venkatraman V; Mavridis L; Ritchie DW
J Chem Inf Model; 2012 Aug; 52(8):1948-61. PubMed ID: 22747187
[TBL] [Abstract][Full Text] [Related]
7. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
8. Creating the next generation of protein therapeutics through rational drug design.
Szymkowski DE
Curr Opin Drug Discov Devel; 2005 Sep; 8(5):590-600. PubMed ID: 16159021
[TBL] [Abstract][Full Text] [Related]
9. Fragments, network biology and designing multiple ligands.
Morphy R; Rankovic Z
Drug Discov Today; 2007 Feb; 12(3-4):156-60. PubMed ID: 17275736
[TBL] [Abstract][Full Text] [Related]
10. Assessment of additive/nonadditive effects in structure-activity relationships: implications for iterative drug design.
Patel Y; Gillet VJ; Howe T; Pastor J; Oyarzabal J; Willett P
J Med Chem; 2008 Dec; 51(23):7552-62. PubMed ID: 19012393
[TBL] [Abstract][Full Text] [Related]
11. Knowledge-based chemoinformatic approaches to drug discovery.
Ghose AK; Herbertz T; Salvino JM; Mallamo JP
Drug Discov Today; 2006 Dec; 11(23-24):1107-14. PubMed ID: 17129830
[TBL] [Abstract][Full Text] [Related]
12. How well do medicinal chemists learn from experience?
Cheshire DR
Drug Discov Today; 2011 Sep; 16(17-18):817-21. PubMed ID: 21704183
[TBL] [Abstract][Full Text] [Related]
13. Informatics and modeling challenges in fragment-based drug discovery.
Hubbard RE; Chen I; Davis B
Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
[TBL] [Abstract][Full Text] [Related]
14. Biocatalysis: synthesis of chiral intermediates for drugs.
Patel RN
Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
[TBL] [Abstract][Full Text] [Related]
15. Knowledgebase for addiction-related genes: is it possible an extrapolation to rational multi-target drug design?
Espinoza-Fonseca LM
Bioorg Med Chem; 2008 Oct; 16(20):9346-8. PubMed ID: 18815048
[TBL] [Abstract][Full Text] [Related]
16. Polypharmacology directed compound data mining: identification of promiscuous chemotypes with different activity profiles and comparison to approved drugs.
Hu Y; Bajorath J
J Chem Inf Model; 2010 Dec; 50(12):2112-8. PubMed ID: 21070069
[TBL] [Abstract][Full Text] [Related]
17. Ligand efficiency indices as guideposts for drug discovery.
Abad-Zapatero C; Metz JT
Drug Discov Today; 2005 Apr; 10(7):464-9. PubMed ID: 15809192
[No Abstract] [Full Text] [Related]
18. Selective optimization of side activities: another way for drug discovery.
Wermuth CG
J Med Chem; 2004 Mar; 47(6):1303-14. PubMed ID: 14998318
[No Abstract] [Full Text] [Related]
19. Furans, thiophenes and related heterocycles in drug discovery.
Sperry JB; Wright DL
Curr Opin Drug Discov Devel; 2005 Nov; 8(6):723-40. PubMed ID: 16312148
[TBL] [Abstract][Full Text] [Related]
20. Role of computer-aided drug design in modern drug discovery.
Macalino SJ; Gosu V; Hong S; Choi S
Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]